Journal article
Safety and efficacy of the surpass streamline for intracranial aneurysms (SESSIA): A multi-center US experience pooled analysis
Interventional neuroradiology, Vol.29(5), pp.589-598
10/2023
DOI: 10.1177/15910199221118148
PMCID: PMC10549718
PMID: 35934939
Abstract
Background and purpose
Flow diversion has established as standard treatment for intracranial aneurysms, the Surpass Streamline is the only FDA-approved braided cobalt/chromium alloy implant with 72-96 wires. We aimed to determine the safety and efficacy of the Surpass in a post-marketing large United States cohort.
Materials and methods
This is a retrospective multicenter study of consecutive patients treated with the Surpass for intracranial aneurysms between 2018 and 2021. Baseline demographics, comorbidities, and aneurysm characteristics were collected. Efficacy endpoint included aneurysm occlusion on radiographic follow-up. Safety endpoints were major ipsilateral ischemic stroke or treatment-related death.
Results
A total of 277 patients with 314 aneurysms were included. Median age was 60 years, 202 (73%) patients were females. Hypertension was the most common comorbidity in 156 (56%) patients. The most common location of the aneurysms was the anterior circulation in 89% (279/314). Mean aneurysm dome width was 5.77 ± 4.75 mm, neck width was 4.22 ± 3.83 mm, and dome/neck ratio was 1.63 ± 1.26. Small-sized aneurysms were 185 (59%). Single device was used in 94% of the patients, mean number of devices per patient was 1.06. At final follow-up, complete obliteration rate was 81% (194/239). Major stroke and death were encountered in 7 (3%) and 6 (2%) cases, respectively.
Conclusion
This is the largest cohort study using a 72–96 wire flow diverter. The Surpass Streamline demonstrated a favorable safety and efficacy profile, making it a valuable option for treating not only large but also wide-necked small and medium-sized intracranial aneurysms.
Details
- Title: Subtitle
- Safety and efficacy of the surpass streamline for intracranial aneurysms (SESSIA): A multi-center US experience pooled analysis
- Creators
- Juan Vivanco-Suarez - University of Iowa Hospitals and ClinicsAlan Mendez-Ruiz - University of IowaMudassir Farooqui - University of IowaKimon Bekelis - Good Samaritan Hospital Medical CenterJustin A Singer - Spectrum HealthKainaat Javed - Montefiore Medical CenterDavid J Altschul - Montefiore Medical CenterJohanna T Fifi - Department of Neurological Surgery, The Mount Sinai Hospital, New York, NY, United StatesStavros Matsoukas - Department of Neurological Surgery, The Mount Sinai Hospital, New York, NY, United StatesJared Cooper - Westchester Medical CenterFawaz Al-Mufti - Westchester Medical CenterBradley Gross - University of Pittsburgh Medical CenterBrian Jankowitz - University of Pittsburgh Medical CenterPeter T Kan - The University of Texas Medical Branch at GalvestonMuhammad Hafeez - The University of Texas Medical Branch at GalvestonEmanuele Orru - Lahey Medical CenterAndres Dajles - University of Iowa Hospitals and ClinicsMilagros Galecio-Castillo - University of Iowa Hospitals and ClinicsCynthia B Zevallos - University of IowaAjay K Wakhloo - Lahey Medical CenterSantiago Ortega-Gutierrez - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Interventional neuroradiology, Vol.29(5), pp.589-598
- DOI
- 10.1177/15910199221118148
- PMID
- 35934939
- PMCID
- PMC10549718
- NLM abbreviation
- Interv Neuroradiol
- ISSN
- 1591-0199
- eISSN
- 2385-2011
- Grant note
- DOI: 10.13039/100008894, name: Stryker, award: 2020-HEM-006
- Language
- English
- Electronic publication date
- 08/08/2022
- Date published
- 10/2023
- Academic Unit
- Neurology; Radiology; Iowa Neuroscience Institute; Neurosurgery
- Record Identifier
- 9984303012802771
Metrics
14 Record Views